Fatigue, a common symptom reported in clinical settings, poses a significant diagnostic challenge due to its multifactorial etiology. This article aims to provide a comprehensive clinical approach for healthcare professionals to understand and manage fatigue.
Fatigue is a subjective feeling of tiredness or lack of energy, often associated with decreased physical and cognitive performance. It can be acute or chronic, with chronic fatigue lasting more than six months. The etiology of fatigue is multifaceted, encompassing physical, psychological, and social factors.
A comprehensive patient history and physical examination are crucial in the assessment of fatigue. The history should focus on the onset, duration, severity, and impact of fatigue on daily activities. Any associated symptoms, medical history, medication use, lifestyle factors, and psychosocial stressors should also be evaluated. Physical examination should aim to identify any signs of systemic disease.
Investigations should be guided by the clinical history and physical examination findings. Basic investigations may include complete blood count, thyroid function tests, liver function tests, and urine analysis. Further investigations may be warranted based on the initial findings.
Management of fatigue should be individualized, addressing the underlying cause(s). This may involve medical management for identified disease, lifestyle modification, psychological intervention, or a combination of these approaches. Regular follow-up is essential to monitor progress and adjust management as needed.
Fatigue can significantly impact a patient's quality of life. A comprehensive clinical approach, integrating a thorough history, physical examination, and appropriate investigations, is key to identifying the underlying cause and providing effective management. Continued education and research are necessary to further our understanding and management of this complex symptom.
1.
Injecting PD-1 Drug Directly Into Oral Precancers Shrinks Lesions
2.
Sevabertinib Approved for First-Line Mutated NSCLC
3.
After three years, responses to mounetuzumab in follicular lymphoma are still stable.
4.
FDA Bans Red Dye No. 3 From Foods, Ingested Drugs
5.
AI can identify women at risk of breast cancer years in advance: Study
1.
Revolutionizing Cancer Treatment: Advances in Immunotherapy and Cell Therapy
2.
Pediatric Tumor Microenvironment Evolution: Mechanisms, Clinical Impact, and Therapeutic Implications
3.
Hematopoietic Stem Cell Activity Biomarkers in Aging
4.
Bone-Marrow Immune Cell Competition: Mechanisms, Clinical Implications, and Emerging Therapeutic Perspectives
5.
The Truth About TAR Syndrome: Understanding the Rare Genetic Disorder
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII
2.
A New Era in Managing Cancer-Associated Thrombosis
3.
Emerging Concepts in Hematology
4.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management- Further Discussion
5.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation